Back باول إرليش Arabic پول ارليخ ARZ Paul Erlix Azerbaijani پول الریخ AZB Паўль Эрліх Byelorussian Паул Ерлих Bulgarian পাউল এরলিখ Bengali/Bangla Paul Ehrlich BS Paul Ehrlich Catalan پاوڵ ئرلیچ CKB

Paul Ehrlich

For other people named Paul Ehrlich, see Paul Ehrlich (disambiguation).

Paul Ehrlich
FRS
Born14 March 1854 (1854-03-14)
Strehlen, Lower Silesia, Prussia (now Strzelin, Poland)
Died20 August 1915 (1915-08-21) (aged 61)
Bad Homburg, Hesse, German Empire
CitizenshipGerman
Known forChemotherapy
Immunology
Basophil
Magic bullet
Mast cell
Receptor theory
Side-chain theory
Ehrlich's reagent
SpouseHedwig Pinkus (1864–1948) (m. 1883; 2 children)
ChildrenStephanie and Marianne
AwardsNobel Prize in Physiology or Medicine (1908)
Cameron Prize of the University of Edinburgh (1914)
Scientific career
FieldsImmunology
Thesis Beiträge zur Theorie und Praxis der histologischen Färbung  (1878)
Notable studentsHans Schlossberger
Signature

Paul Ehrlich (German: [ˈpaʊl ˈʔeːɐ̯lɪç] ; 14 March 1854 – 20 August 1915) was a Nobel Prize-winning German physician and scientist who worked in the fields of hematology, immunology and antimicrobial chemotherapy. Among his foremost achievements were finding a cure for syphilis in 1909 and inventing the precursor technique to Gram staining bacteria. The methods he developed for staining tissue made it possible to distinguish between different types of blood cells, which led to the ability to diagnose numerous blood diseases.

His laboratory discovered arsphenamine (Salvarsan), the first antibiotic and first effective medicinal treatment for syphilis, thereby initiating and also naming the concept of chemotherapy. Ehrlich introduced the concept of a magic bullet. He also made a decisive contribution to the development of an antiserum to combat diphtheria and conceived a method for standardising therapeutic serums.[1]

In 1908, he received the Nobel Prize in Physiology or Medicine for his contributions to immunology.[2] He was the founder and first director of what is now known as the Paul Ehrlich Institute, a German research institution and medical regulatory body that is the nation's federal institute for vaccines and biomedicines. A genus of Rickettsiales bacteria, Ehrlichia, is named after him.[3]

Ehrlich has been called "father of immunology".[4][5]

  1. ^ "Paul Ehrlich". Science History Institute. June 2016. Retrieved 20 March 2018.
  2. ^ "The Nobel Prize in Physiology or Medicine 1908, Paul Ehrlich – Biography".
  3. ^ Thomas, Sunil; Popov, Vsevolod L.; Walker, David H. (20 December 2010). "Exit Mechanisms of the Intracellular Bacterium Ehrlichia". PLOS ONE. 5 (12): e15775. Bibcode:2010PLoSO...515775T. doi:10.1371/journal.pone.0015775. ISSN 1932-6203. PMC 3004962. PMID 21187937.
  4. ^ https://www.kcr.uky.edu/training/fall18/Immunotherapy%20for%20Cancer%20%20final.pptx [bare URL]
  5. ^ "A Look Ahead XVIII: Explorations in Transformative Research". YouTube. 16 April 2015.

Developed by StudentB